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Abstract
Objective: While the physical and psychosocial benefits of participating in physical activity
(PA) during and following breast cancer treatment are well understood, less is known about
rates and uptake of PA following diagnosis. This paper explores the levels and patterns of PA
among women recently diagnosed with breast cancer and the factors associated with change in
activity levels.
Methods: Using a population-based recruitment approach, PA levels of 287 breast cancer
patients were assessed at 6, 12 and 18 months post-diagnosis using the Behavioral Risk Factor
Surveillance System, and then converted to MET (metabolic equivalent task)-hours/week.
Regression analyses were used to explore the correlates associated with change between 6 and
18 months post-diagnosis.
Results: Although more than 80% of women participated in PA at each testing phases,
more than 50% were considered insufficiently active or sedentary according to national
recommendations and less than one-third reported engagement in vigorous or strength
activities. Mean change in total MET-hours/week between 6 and 18 months post-diagnosis was
minor (mean5 0.10, median5 0.0), however individual changes were substantial (ranging from
100 to +174 MET-hours/week). Results are more encouraging for the lower threshold of 3+
MET-hours/week, which may be most relevant specifically for breast cancer outcomes.
Conclusions: Since the majority of women report insufficient levels of PA, there is a clear
need for exercise interventions during and following breast cancer treatment. Few
characteristics predict declines or improvements in PA levels, hence for optimal benefit,
interventions should target the entire breast cancer population.
Copyright r 2008 John Wiley & Sons, Ltd.
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Introduction
Research examining exercise interventions among
women with breast cancer has been extensively
reviewed in recent years [1–4]. Published results
show that participation in physical activity (PA)
during or following breast cancer treatment is
associated with increased functional capacity, de-
creased fatigue and nausea, improved body image
and body composition, stronger immune function,
more positive self-esteem and mood, better adjust-
ment to illness, reduced emotional distress, depres-
sion and anxiety, and consequently, enhanced
quality of life. Evidence also demonstrates
a relationship between PA participation and
improved survival and reduced risk of recurrence
following breast cancer [5, 6], in particular for those
walking 3 or more hours/week at an average pace or
at equivalent levels (commensurate with 9+ MET
(metabolic equivalent task)-hours/week activity) [5].
However, observational studies have also shown
30–40% reductions in overall mortality among
women with breast [5] or colorectal cancer [7] at
lower levels of PA equivalent to 3–8.9 MET-hours/
week, although confidence intervals were wide and
results were not necessarily statistically significant.
Despite compelling evidence that participation
in exercise is beneficial for women with breast
cancer, only 15–44% are engaged in some form of
PA during or following breast cancer treatment
[8–10], and only 20–30% of these women meet
national recommendations [8]. Further, PA
generally decreases during the active treatment
stage [11–13], with greater declines being reported
in vigorous-intensity activity compared with
moderate-intensity activity, and for those treated
with surgery and chemotherapy vs surgery alone or
in combination with radiation [14]. Opinion is
divided as to how long it takes for PA to resume to
pre-diagnosis levels, if it does at all [15].
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Characteristics influencing participation in PA
or changes in PA during and following breast
cancer are of clinical interest. Research on PA
participation has historically focused attention on
the role of beliefs, attitudes, intentions, confidence
and motivation in various populations [16, 17].
However, we have observed these to change over
time among women undergoing treatment for
breast cancer (based on a current randomized
controlled trial of exercise intervention among
women with breast cancer), and these changes are
related to personal, treatment and health-related
characteristics. In addition to treatment type [14],
older age [8, 15], higher body mass index [18] and
more advanced disease [8] have been associated
with more sedentary lifestyles, while social support
[15], having an exercise role model or partner [19]
and higher income [19] have been positively linked
with exercise participation among breast cancer
survivors. Unfortunately, the majority of studies
assessing PA after a breast cancer diagnosis have
been cross-sectional or retrospective in design. The
Pulling Through Study (PTS) was a longitudinal,
population-based investigation of the physical and
psychosocial recovery of women diagnosed with
breast cancer and collected information on self-
reported PA. This paper therefore describes the
levels of PA and the demographic, treatment and
health-related factors associated with change in PA




The Queensland Cancer Registry was used to
randomly select 511 women with primary, invasive,
unilateral breast cancer (diagnosed in 2002), aged
between 20 and 74 years, and residing within a
100 km radius of Brisbane, Queensland. Eligibility
criteria reflected the requirements of the PTS,
specifically, the residence criteria allowed for travel
to the University for clinical assessments, while
unilateral disease allowed for the untreated arm to
serve as an internal control for upper-body
measures (e.g. lymphoedema) [20, 21]. Women
younger than 50 years of age were over-sampled to
allow sufficient numbers for age-specific analyses,
because the risk and implications of breast cancer
both differ by age. In accordance with required
protocol and following ethical approval, the
treating doctor’s consent was sought and obtained
for 417 women (82%), and participant consent was
then obtained from 296 women (71%). Subse-
quently, two women were deemed ineligible and a
further seven later declined participation or were
unable to be re-contacted, hence 287 (69%) women
completed the baseline questionnaire. Numbers
vary in specific analyses due to some loss-to-follow-
up (n5 15) and missing data (less than 10% of
initial sample).
Data collection involved the completion of a
participant-administered questionnaire every 3
months over a 12-month period, with baseline
measures being assessed at 6 months following
breast cancer diagnosis. Information pertaining to
personal characteristics (age, marital status, num-
ber and ages of children, employment, income,
health insurance coverage), treatment-related char-
acteristics (surgery, chemotherapy, radiotherapy,
lymphedema status, presence of complications, side
of treatment with respect to handedness), general
health characteristics (weight, smoking status,
stress levels and coping with stress, quality of life)
and PA were collected via the questionnaires
(specific questions available upon request). Quality
of life was assessed using the Functional Assess-
ment of Cancer Therapy—Breast (+4) [22] with
the addition of the arm morbidity subscale [23].
Tumor characteristics (histological type, grade,
tumor size, lymph node status) were abstracted
from pathology reports located at the Queensland
Cancer Registry.
PA assessment
PA levels were assessed using questions from the
Behavioral Risk Factor Surveillance System [24].
Women were asked to describe the type and
amount (number of days per week and minutes
per day) of activity, including vigorous, moderate
and strength activities, undertaken during a ‘usual’
week during the prior 3 months. To assist
respondents with accurate recall, examples of
activities were listed as well as descriptions of what
represents vigorous- and moderate-intensity exer-
cise. Good to excellent reproducibility (kap-
pa5 0.52–0.83, with 77–93% agreement) have
been demonstrated with these questions [25].
Statistical methods
Weekly minutes of vigorous, moderate and
strength activities were calculated by multiplying
the number of days per week by the number of
minutes per day reported by the woman. PA levels
at 6, 12 and 18 months post-diagnosis are
described. As distributions were highly skewed,
medians and means are presented to aid interpreta-
tion of the data. Women were then categorized
according to national PA guidelines [26]. These
recommendations equate to participating in mod-
erate-intensity activity on 5 or more days for at
least 30min or vigorous activity on 3 or more days
for at least 20min. Based on this definition, women
were classified as sedentary (reported no activity),
insufficiently active (some activity but less than
guidelines) or meeting guidelines (at or above
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recommendations). Finally, MET values were
assigned to each type of activity based on intensity
(4.0 for moderate activity and 8.0 for vigorous
activity as specified in the International PA
Questionnaire [27]). One MET is considered the
resting metabolic rate obtained during quiet sitting
[28]. Assigned MET values were multiplied by the
number of hours per week (truncated at 21 h/week
[27]) to obtain the weekly MET-hours for each
activity. Total MET-hours of weekly activity were
then calculated by summing the amounts of
vigorous and moderate activity. Of note,
strength-based activity was not converted into
MET-hours.
The change in total MET-hours of weekly
activity between 6 and 18 months post-diagnosis
was calculated and bivariate statistics were used to
assess the unadjusted relationship between change
in MET-hours of weekly activity and each baseline
patient, treatment and behavioral characteristic
(total of 22 characteristics evaluated). Character-
istics of potential theoretical (known from the
literature), statistical (po0.1) or clinical signifi-
cance (defined as a mean change or difference
between groups of 3 MET-hours/week of activity)
were incorporated into four separate linear-regres-
sion models (described as patient, treatment,
treatment-related complications and behavioral
characteristics models) to assess the independent
relationships among inter-related characteristics.
To further consider independent relationships,
those that continued to show associations of
potential clinical importance with p-values of less
than 0.2 were included in one final model. The
PROC REGRESS procedure was implemented
using SUDAAN (Release 9.0.1) and results are
expressed as means and 95% confidence intervals
(CIs), with a two-tailed po0.05 taken as evidence
of statistical significance. All analyses were
weighted to take into account the over-sampling
of younger women.
Results
Similar demographic and disease characteristics
were observed for the women in this study
compared with those in the target sample of all
potentially eligible women diagnosed with breast
cancer during 2002 (Table 1). Average age of the
women was 55 years and the majority were
diagnosed with infiltrating ductal/ductal carcinoma
NOS (72%), received less invasive surgery (com-
plete local excision) (73%) and had some degree of
lymph node dissection (87%). At baseline assess-
ment, 16% of the sample was still receiving
chemotherapy, 11% radiation therapy and 33%
hormone therapy. Active adjuvant therapy de-
clined over time, and by 12 months post-diagnosis,
fewer than 2% continued to receive radiation
therapy or chemotherapy, although 31% remained
on hormone therapy.
PA levels
Table 2 describes the minutes of weekly PA
reported by women at 6, 12 and 18 months post-
diagnosis. Over 80% of the sample reported
participating in moderate-intensity activity, with
medians ranging between 167 and 150min/week
from 6 to 18 months post-diagnosis. Less common
was participation in vigorous and strength activ-
ities at baseline, with only 23% and 20% of women
reporting these activities at means of 52 and
25min/week, respectively. Participation in these
activities increased modestly over time to 37 and
31% of women, respectively, at 18 months post-
diagnosis, although these results were not statisti-
cally significant.
The most commonly reported PA was walking
with 70% of women listing walking in the
moderate-intensity category and 34% in the
vigorous-intensity category at 18 months post-
diagnosis. The other most commonly reported
‘vigorous’ activities were heavy yard work, garden-
ing and aerobics, listed by 18, 15 and 11% of
women, respectively. Over 33 other types of
activities were also listed under the vigorous-
intensity category and included those more
Table 1. Demographic and clinical characteristics of the target
samplea and participant groupb, the Pulling Through Study,
Brisbane, Australia
Target sample Participant group
N 511 287
Age
mean years7std dev 54 (710) 55 (710)
Most extensive surgery % %
Complete local excision 72.2 72.5
Mastectomy 27.8 27.5
Largest tumor size (mm)
median 14 14
(minimum, maximum) (0.3–230) (0.50–140)
Lymph node dissection
Yes 86.3 86.7
Number of nodes removed










Infiltrating lobular 12.4 15.7
Other mixed type 9.4 11.8
aTarget sample refers to the random sample obtained from the pool of all women
diagnosed with breast cancer in the population-based Queensland Cancer
Registry after application of eligibility criteria.
bResults presented have been appropriately weighted (o50 years:1.0;X50
years:1.3) for oversampling of younger women.
Physical activity following breast cancer
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typically associated with vigorous intensities such
as tennis, squash, rowing, dancing and bike-riding;
however, these were less common, being reported
by only 1–4% of women. The second most
commonly reported moderate-intensity activity
was vacuuming, followed by gardening, listed by
42 and 36% of the women, respectively.
Using reported PA levels that included house-
hold-related tasks (e.g. vacuuming), women were
categorized according to national PA guidelines,
and less than half the group (46%) was considered
sufficiently active throughout the 12-month period
(Table 3). There was a small decline in sedentary
women at 18 months post-diagnosis, and large
differences in the median levels of activity reported
by sufficiently and insufficiently active women at all
time points (33–35 vs 8–9 MET-hours/week,
respectively po0.001). Between 77 and 82% met
the threshold of 3+ MET-hours/week of PA
during the same time period.
Change in PA levels between 6 and 18 months
post-diagnosis
Overall change in MET-hours/week for total
(includes vigorous and moderate activity) and
hours/week of strength-based activities between 6
and 18 months post-diagnosis was negligible
(mean5 0.10 MET-hours/week and 0.22 hours/
week, respectively; median5 0.0 for both groups).
This obscures variation in individual change, which
was potentially substantial, with total activity
changes ranging from 100 to +174 MET-hours/
week and strength-based activities ranging from 7
to 113 h/week. Further, approximately 60% of
women categorized as being sedentary at 6 and/or
12 months post-diagnosis increased their activity
levels enough to be reclassified, with approximately
half becoming insufficiently active and the other
half sufficiently active. One-third of women con-
sidered sufficiently active at 6 and/or 12 months
post-diagnosis reduced their activity over time,
with about 30% of these women becoming
sedentary and the remainder being classified as
insufficiently active. Of those considered ‘insuffi-
ciently active’ at 6 and/or 12 months post-
diagnosis, the majority remained insufficiently
active over time. Of the 40% that changed their
activity levels, women were more than two times
more likely to increase their activity than to
decrease their activity.
Of those who report o3 MET-hours/week of
total activity at 6 and 12 months post-diagnosis,
approximately 60% increase activity levels to 31
MET-hours/week at 18 months. Conversely,
among those reporting 31 MET-hours of total
Table 2. Minutes of weekly physical activity reported by women with breast cancer at 6, 12 and 18 months post-diagnosisa
6 months 12 months 18 months
n5287 n5277 n5272
Vigorous po0.001b
Median (min, max) 0.0 (0.0, 1260.0) 0.0 (0.0, 960.0) 0.0 (0.0, 1260.0)
Mean (SE) 52.1 (8.2) 55.1 (7.4) 70.6 (8.4)
n (%) women reported activity 69 (23.3%) 76 (27.3%) 100 (36.5%)
Moderate po0.001b
Median (min, max) 166.5 (0.0, 3360.0) 165.0 (0.0, 2520.0) 150.0 (0.0, 2100.0)
Mean (SE) 282.7 (24.7) 306.9 (25.7) 227.4 (17.3)
n (%) women reported activity 235 (82.1%) 240 (86.3%) 233 (85.4%)
Strength po0.001b
Median (min, max) 0.0 (0.0, 420.0) 0.0 (0.0, 525.0) 0.0 (0.0, 750.0)
Mean (SE) 25.0 (3.9) 31.7 (4.4) 38.6 (5.4)
n (%) women reported activity 58 (20.3%) 75 (27.2%) 84 (30.7%)
aResults presented have been appropriately weighted (o50 years:1.0; X50 years:1.3) for oversampling of younger women.
bp values reflect the statistical significance of changes in the mean overtime.
Table 3. Proportionsa of women meeting physical activity guidelinesb and corresponding met-hours of total weekly activityc at 6, 12
and 18 months following diagnosis of breast cancer
6 Months 12 Months 18 Months






Sedentary 51 (18.0) 0.0 (0.0, 0.0) 37 (14.1) 0.0 (0.0, 0.0) 39 (14.9) 0.0 (0.0, 0.0)
Insufficiently active 98 (35.4) 8.2 (2.0, 48.0) 108 (39.3) 9.3 (0.7, 56.0) 111 (40.9) 9.3 (0.7, 134.0)
Meeting guidelines 129 (46.4) 33.1 (8.0, 168.0) 125 (46.3) 35.3 (10.0, 156.0) 119 (44.3) 33.4 (10.0, 238.0)
31METS 219 (76.8) 20.0 (3.3, 168.0) 226 (81.5) 20.0 (3.0, 156.0) 225 (82.4) 18.7 (3.0, 238.0)
aResults presented have been appropriately weighted (o50 years:1.0; X50 years:1.3) for over-sampling of younger women.
bPhysical activity guidelines defined as 30min of moderate activity, 5 or more days per week, or 20min of vigorous activity on 3 or more days per week.
cTotal activity5 vigorous+moderate intensity activities.
S. Harrison et al.
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activity per week at 6 and/or 12 months, approxi-
mately 10% reported lower levels of activity (o3
MET-hours/week) at 18 months post-diagnosis.
Predictors of change in PA levels
Of the 22 characteristics evaluated, nine showed
associations with change in PA levels from 6 to 18
months following breast cancer diagnosis, after
mutual adjustment for each other (Table 4), which
were of potential clinical importance (i.e., increase or
decrease of 31MET-hours/week). Collectively, these
nine characteristics explain 35% of variance in the
outcome variable (F57.92, df518, po0.01). The
coefficient for baseline PA revealed a statistically
significant, inverse association (beta50.50,
po0.01), suggesting an overall decline among those
who were active at baseline but also consistent with
regression to the mean. The only other statistically
significant factor was treatment-related complica-
tions. Although those who experienced one or more
treatment-related complications reported a modest
decline in total PA levels, on average, their counter-
parts (i.e., those not having complications) reported
substantial average increases of 17.7 (95% CI: 3.0,
32.4) MET-hours/week, respectively, between 6 and
18 months post-diagnosis.
The remaining characteristics in the final model
showed potentially meaningful changes in total PA
levels for at least one subgroup, however the
confidence intervals were wide and the results were
not statistically significant.
Discussion
The vast majority of women (480%) in this study
reported engaging in some PA between 6 and 18
months following breast cancer diagnosis, predo-
minantly comprising moderate-intensity activities,
with only 20–30% reporting either vigorous-
intensity or strength-based exercise. However, only
around 45% of these breast cancer survivors met
current national guidelines for sufficient PA. Over-
all these levels of exercise changed very little during
Table 4. Predictors of change in total physical activity (MET-hours/week)a from 6 to 18 months following breast cancer diagnosis
Crudeb Adjusted resultsbc
n Mean change Mean change 95% CI p-value
Age 0.81
65+ 48 1.7 4.2 (6.7, 15.2)
55–64 81 1.3 0.9 (6.1, 4.3)
45–54 93 1.2 0.8 (4.8, 3.3)
o45 49 1.5 2.4 (8.4, 3.6)
Income 0.61
Missing 32 4.5 1.9 (8.4, 4.6)
4$52 000 91 0.6 1.7 (3.3, 6.7)
$26 000–$51 000 71 4.0 2.9 (4.6, 10.4
o$26 000 77 5.1 4.0 (10.0, 2.0)
Surgery 0.18
Mastectomy 93 0.1 3.4 (9.2, 2.4)
CLE 178 0.2 1.6 (1.9, 5.0)
Radiotherapy 0.06
Yes 206 2.2 1.7 (4.9, 1.6)
No 65 6.7 4.9 (1.0, 10.8)
Number of lymph nodes removed 0.13
20+ 39 0.4 0.8 (8.3, 6.6)
10–19 116 3.1 3.8 (1.7, 9.2)
o10 80 5.9 4.8 (8.7, 0.9)
None 36 1.9 1.4 (7.5, 4.7)
Baseline smoking status 0.18
Current 26 1.2 4.6 (6.1, 15.3)
Past 83 5.4 3.4 (3.4, 10.2)
Never 162 3.1 2.6 (5.4, 0.2)
FACTB+4 baseline 0.08
Lower 25% 64 3.1 4.5 (1.4, 10.4)
Middle 50% 139 0.8 0.6 (2.8, 3.9)
Top 25% 68 4.7 5.4 (11.8, 1.0)
Treatment complications 0.01
One or more 243 2.1 2.2 (4.8, 0.4)
None 28 16.9 17.7 (3.0, 32.4)
aTotal activity5moderate+vigorous-intensity activities and change in physical activity5 18 months–6 months MET-hours/week.
bResults presented have been appropriately weighted (o50 years:1.0; X50 years:1.3) for over-sampling of younger women.
cResults are adjusted for all other variables in the table and baseline MET-hours/week of total activity.
FACTB14, Functional Assessment of Cancer Therapy-Breast questionnaire.
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the time-frame studied, but this result obscured
substantial variation among individuals, with both
increases and decreases taking place. The most
encouraging findings relate to the large number of
women in this study who reported 3 or more MET-
hours/week of activity. This modest level appears
to be the level at which quality of life and survival
benefits begin to accrue for women with breast
cancer [5, 6, 29, 30] or colorectal cancer [7, 31],
although higher levels are often associated with
larger and/or more statistically significant benefits.
Reliance on national guidelines for determining
suitable levels of activity for women during and
following treatment for breast cancer is a major
issue, as these recommendations were developed
largely in relation to cardiovascular health and not
cancer outcomes. Reviews of exercise and breast
cancer studies report physical and psychosocial
benefits for women who regularly participated in
much lower levels of PA during or following breast
cancer treatment [1, 3, 4, 29]. Prescriptive char-
acteristics of studies varied but ranged from 1–6
days/week with durations of 15–60min/session and
low to moderate intensities (50–85% of maximal
effort/heart rate). The most common type of
activity studied has been aerobic-based activity,
in particular walking, although similar benefits
have been shown in studies also utilizing resistance-
based activity [32–34]. A typical exercise prescrip-
tion involved participating in aerobic-based
activity at least three times per week for approxi-
mately 20min or more duration. This is equivalent
to 3 or more MET-hours of PA per week.
The women in this study reported similar levels
of PA when compared with levels in the general
population derived from a state-wide survey
conducted in Queensland, where Brisbane is the
capital city [35], even at 6 months post-diagnosis.
Similar findings have been reported in the United
States [36–38], although these studies compared
breast cancer survivors 10 years post-diagnosis
with the general population. While this informa-
tion highlights the universal lack of PA among
Australian (and other) women, it also signifies the
importance of taking advantage of the ‘teachable’
moment after a cancer diagnosis [39]. Women may
be more amenable to behavior change following a
breast cancer diagnosis, particularly with the
advice and guidance of clinicians and allied health
professionals. However, it seems plausible that
only a small window of opportunity exists to
encourage these lifestyle changes beyond the
immediate recovery period, when the return to
normal routines once again makes such personal
commitments challenging.
This lack of change in average PA levels between
6 and 18 months post-diagnosis supports findings
of others, also showing no change in PA in a breast
cancer cohort between 8 and 20months following
diagnosis [15]. However, as mentioned previously,
individual variation in this study was considerable
and of clinical importance, with some women
increasing and others decreasing activity levels
over time. There was also movement between PA
categories (sedentary, insufficiently active and
sufficiently active), with approximately 40% of
women changing over time. Of these, about half
increased their activity levels, while the others
reported declines in exercise. It is worthwhile to
note that, irrespective of change, more than 60% of
women were not participating in any vigorous-
intensity or strength-based activity at any phase.
These types of activities have a particular role
in optimizing functional capacity as well as
maintenance of lean tissue and healthy body
composition.
Despite the individual variability, few patient,
treatment and behavioral characteristics were
found to be clinically important predictors of
change in PA levels. Only two were also statisti-
cally significant, namely baseline PA and treat-
ment-related complications. The first showed an
inverse relationship suggesting that higher levels of
baseline activity predicted lower levels at 18
months following diagnosis. The other one indi-
cated that in the absence of potential barriers, i.e.,
treatment-related complications, women were more
likely to increase their PA levels. Whereas women
of lower socioeconomic status or receiving a
mastectomy instead of local excision might be
expected to experience decreases in PA, having
fewer (1–9) lymph nodes dissected and/or high
quality of life at baseline also were associated with
declines of 3 or more MET-hours/week and are
harder to explain. In contrast, being ‘middle-class’,
not receiving radiotherapy, having 10–19 lymph
nodes removed, being a current or past smoker and
poor quality of life at baseline were associated with
increases in PA levels of 3 or more MET-hours/
week during the study period. The clinical applica-
tion of this information is limited. While ideally
assessment of the presence or absence of these
characteristics could help identify those in greatest
need of exercise advice, given the lack of obvious
explanatory mechanisms and the likelihood that at
least some of these associations reflect regression to
the mean, it seems more appropriate for exercise
advice to be general and inclusive.
Some comment regarding measurement of PA is
also warranted. The method used to assess PA
levels in this study allowed for inclusion of house-
hold-related tasks. It is therefore possible that the
‘real’ proportion of sufficiently active women has
been over-estimated, particularly since the studies
demonstrating cancer-related benefits focused on
leisure-time exercise. It is also plausible that
activity levels were over-estimated as a conse-
quence of misinterpretation of moderate and
vigorous intensity. For example, activities such as
walking, gardening and lawn bowls were reported
S. Harrison et al.
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as vigorous intensity by some. While it is possible
for such activities to cause a response reflecting
vigorous-intensity activity, this is likely the case
only for specific subgroups of women (e.g. older
women and/or those who have become signifi-
cantly de-conditioned as a consequence of exten-
sive treatment). However, the reporting of these
types of activities was not restricted to women of
particular ages or treatment characteristics. Simple
over-reporting of the amount of activity also may
have contributed to the results. Just over 7%
reported activity levels that exceeded 1260min
(21 h) per week of vigorous or moderate activity,
requiring truncations in the regression analysis of
change. Errors in interpreting exercise intensity
and/or over-reporting of PA levels are known
limitations of self-reported PA [40], so it is expected
that the same problems will occur when such
measures are used with breast cancer cohorts.
Nonetheless, self-reported measures have been
shown to be reliable [41], hence they can be used
to capture change in activity levels over time.
These findings are derived using a population-
based representative sample of women with breast
cancer and reflect a clinical profile similar to that
observed in studies from most Western countries.
Therefore, conclusions derived from this work are
likely generalizable to the broader population of
women with breast cancer, not only in Australia,
but also to urban breast cancer survivors inter-
nationally. Further, the longitudinal, prospective
design minimized recall bias and allowed the
temporal relationships between change in PA levels
and other characteristics to be more clearly
established than would have been the case in
cross-sectional or even retrospective study designs.
The primary limitations reflect those inherent with
self-reported or assessor-administered PA ques-
tionnaires. Additionally, because this study was not
designed to specifically evaluate change in PA
participation, data were not available on psycho-
logical constructs of potential interest.
Sufficient evidence exists to support the use of
PA in reducing side effects and increasing quality of
life during and following breast cancer treatment,
with emerging evidence-linking activity to
improved survival. Results of this work are
encouraging, with the majority of women ‘doing
something’. However, there is clearly room for
improvement and we must now develop a better
understanding of how to assist women in becoming
and staying active into long-term survivorship.
Only then will we be able to translate evidence into
practice and thus influence public health.
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